Portola Pharmaceuticals CEO Scott Garland's 2019 pay falls 24% to $4.4M
Portola Pharmaceuticals reports 2019 executive compensation
By ExecPay News
Published: April 20, 2020
Portola Pharmaceuticals reported fiscal year 2019 executive compensation information on April 20, 2020.
In 2019, five executives at Portola Pharmaceuticals received on average a compensation package of $3.3M, a 11% decrease compared to previous year.
Average pay of disclosed executives at Portola Pharmaceuticals
Scott Garland, Chief Executive Officer, received $4.4M in total, which decreased by 24% compared to 2018. 57% of Garland's compensation, or $2.5M, was in option awards. Garland also received $410K in non-equity incentive plan, $650K in salary, $816K in stock awards, as well as $8.4K in other compensation.
For fiscal year 2019, the median employee pay was $291,408 at Portola Pharmaceuticals. Therefore, the ratio of Scott Garland's pay to the median employee pay was 15 to one.
Sheldon L. Koenig, Executive Vice President, Chief Commercial Officer, received a compensation package of $3.5M. 57% of the compensation package, or $2M, was in option awards.
Ernie Meyer, Chief Human Resources Officer, earned $3.2M in 2019, a 12% increase compared to previous year.
John B. Moriarty, Jr., General Counsel, received $2.8M in 2019, which decreases by 35% compared to 2018.
Mardi C. Dier, Executive Vice President, Chief Financial and Business Officer, earned $2.8M in 2019, a 11% increase compared to previous year.
Related executives
Scott Garland
Portola Pharmaceuticals
Chief Executive Officer
Mardi Dier
Portola Pharmaceuticals
Executive Vice President, Chief Financial and Business Officer
John Moriarty
Portola Pharmaceuticals
General Counsel
Ernie Meyer
Portola Pharmaceuticals
Chief Human Resources Officer
Sheldon Koenig
Portola Pharmaceuticals
Executive Vice President, Chief Commercial Officer
You may also like
Source: SEC filing on April 20, 2020.